Alan C. Herman, Chief Scientific Officer at Coherus BioSciences, Inc. (CHRS), sold 18,416 shares at $29.25 ($529K) on 2015-11-02, disclosed to the SEC on 2015-11-04.
Scheduled sale ($529k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.65 | 16,516 | $473K | 89.5% |
| 2 | $29.25 | 1,900 | $56K | 10.5% |
| Total | $28.71 avg | 18,416 | $529K | 100% |
| Filing → |
| CHRS | SELL | 2017-06-05 | $424K | — | Filing → |
| CHRS | SELL | 2017-05-03 | $227K | — | Filing → |
| CHRS | SELL | 2017-04-05 | $470K | — | Filing → |